company background image
COLO B logo

Coloplast CPSE:COLO B Lagerbericht

Letzter Preis

DKK 848.80

Marktkapitalisierung

DKK 190.8b

7D

3.7%

1Y

1.1%

Aktualisiert

26 Jun, 2024

Daten

Finanzdaten des Unternehmens +

Coloplast A/S

CPSE:COLO B Lagerbericht

Marktkapitalisierung: DKK 190.8b

COLO B Aktienübersicht

Coloplast A/S entwickelt und vertreibt Produkte und Dienstleistungen im Bereich der Intimpflege in Dänemark, den Vereinigten Staaten, dem Vereinigten Königreich, Frankreich und international.

Über das Unternehmen

COLO B grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung3/6
Künftiges Wachstum2/6
Vergangene Leistung2/6
Finanzielle Gesundheit1/6
Dividenden3/6

Belohnungen

3.5% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt
Prognostiziertes Gewinnwachstum 12.49% pro Jahr
Die Erträge sind in den letzten 5 Jahren um 4.9% pro Jahr gestiegen.

Risikoanalyse

Die Verschuldung ist durch den operativer Cashflow nicht gut gedeckt
Die Dividende von 2.53% ist nicht ausreichend durch Gewinne oder Cashflows gedeckt.
Die Aktionäre wurden im vergangenen Jahr verwässert

Coloplast A/S Wettbewerber

Demant

CPSE:DEMANT

DKK 67.4b

Ambu

CPSE:AMBU B

DKK 36.1b

Cooper Companies

NasdaqGS:COO

US$17.8b

HOYA

TSE:7741

JP¥6.7t

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Coloplast
Historische Aktienkurse
Aktueller AktienkursDKK 848.80
52-Wochen-HochDKK 977.60
52-Wochen-TiefDKK 689.20
Beta0.31
11 Monat Veränderung-1.21%
3 Monate Veränderung-8.97%
1 Jahr Veränderung1.10%
33 Jahre Veränderung-17.51%
5 Jahre Veränderung6.31%
Veränderung seit IPO6,542.79%

Aktuelle Nachrichten und Updates

Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

May 21
Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

May 10
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

May 09
Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

Recent updates

Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

May 21
Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

May 10
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

May 09
Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Apr 26
A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Apr 08
There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Is Coloplast (CPH:COLO B) A Risky Investment?

Mar 21
Is Coloplast (CPH:COLO B) A Risky Investment?

Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Jan 09
Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

Dec 22
Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 04
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

Nov 16
Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Sep 30
A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Is Coloplast (CPH:COLO B) A Risky Investment?

Jun 28
Is Coloplast (CPH:COLO B) A Risky Investment?

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Jun 10
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Mar 22
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

Mar 01
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 14
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 26
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Nov 25
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 11
Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Oct 25
With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

Aug 26
Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jul 27
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Jul 12
Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

May 23
Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

May 08
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly

Apr 13
Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly

Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock

Mar 29
Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock

Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate

Feb 12
Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate

Coloplast (CPH:COLO B) Could Easily Take On More Debt

Jan 12
Coloplast (CPH:COLO B) Could Easily Take On More Debt

Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?

Dec 28
Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?

Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All

Nov 25
Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All

A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Oct 31
A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly

Oct 02
Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly

Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?

Sep 16
Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?

Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?

Aug 02
Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Jul 01
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Does Coloplast (CPH:COLO B) Deserve A Spot On Your Watchlist?

Jun 16
Does Coloplast (CPH:COLO B) Deserve A Spot On Your Watchlist?

Aktionärsrenditen

COLO BDK Medical EquipmentDK Markt
7D3.7%2.5%1.8%
1Y1.1%5.3%43.1%

Rendite im Vergleich zur Industrie: COLO B unter dem Niveau der Branche Danish Medical Equipment , die im vergangenen Jahr eine Rendite von 4.3% erzielte.

Rendite vs. Markt: COLO B hinter dem Markt Danish zurück, der im vergangenen Jahr eine Rendite von 37.7 erzielte.

Preisvolatilität

Is COLO B's price volatile compared to industry and market?
COLO B volatility
COLO B Average Weekly Movement3.5%
Medical Equipment Industry Average Movement5.7%
Market Average Movement4.5%
10% most volatile stocks in DK Market9.8%
10% least volatile stocks in DK Market2.8%

Stabiler Aktienkurs: COLO B hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.

Volatilität im Zeitverlauf: COLO BDie wöchentliche Volatilität (3%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

GegründetMitarbeiterCEOWebsite
195415,930Kristian Villumsenwww.coloplast.com

Coloplast A/S entwickelt und vertreibt Produkte und Dienstleistungen im Bereich der Intimpflege in Dänemark, den Vereinigten Staaten, Großbritannien, Frankreich und international. Das Unternehmen ist in den Segmenten Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology und Advanced Wound Care tätig. Es bietet Produkte für die Stomaversorgung an, darunter SenSura Mio, das sich an individuelle Körperformen anpasst und optimale Diskretion für verschiedene Arten von Stomata bietet, sowie SenSura Ostomy-Versorgungslösungen und Stomazubehör unter der Marke Brava.

Coloplast A/S's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Coloplast im Vergleich zum Marktanteil des Unternehmens?
COLO B grundlegende Statistiken
MarktanteilDKK 190.84b
Gewinn(TTM)DKK 4.97b
Umsatz(TTM)DKK 25.53b

38.4x

Kurs-Gewinn-Verhältnis

7.5x

Kurs-Umsatz-Verhältnis

Ist COLO B zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
COLO B Gewinn- und Verlustrechnung (TTM)
EinnahmenDKK 25.53b
Kosten der EinnahmenDKK 8.39b
BruttogewinnDKK 17.14b
Sonstige AusgabenDKK 12.17b
UmsatzDKK 4.97b

Zuletzt gemeldete Gewinne

Mar 31, 2024

Datum des nächsten Gewinnberichts

Aug 20, 2024

Gewinn per Aktie (EPS)22.08
Bruttomarge67.13%
Nettogewinnspanne19.45%
Schulden/Eigenkapital-Verhältnis144.9%

Wie hat sich COLO B auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

2.5%

Aktuelle Dividendenrendite

94%

Ausschüttungsquote